Abstract
End-stage renal disease (ESRD) is a debilitating, costly, and increasingly common condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives.
References
Ansell D., Feest T. (1999). UK Renal Registry Report 1999. Bristol, The Renal Association
Ansell D., Feest T., Byrne C., Ahmad A. (2003). UK Renal Registry Report 2003. Bristol, The Renal Association
Aron D.C., Harper D.L., Shepardson L.B., Rosenthal G.E. (1998). Impact of risk-adjusting cesarean delivery rates when reporting hospital performance. Journal of the American Medical Association, 279(24): 1968–1972
Ashton, T., & Marshall, M. R. (2007). The organization and financing of dialysis and kidney transplantation services in New Zealand. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9023-x
Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) (2005). Registry Report. Adelaide: ANZDATA.
Birkmeyer J.D., Sharp S.M., Finlayson S.R., Fisher E.S., Wennberg J.E. (1998). Variation profiles of common surgical procedures. Surgery, 124, 917–923
Birkmeyer J.D., Siewers A.E., Finlayson E.V.A., Stukel T.A., Lucas F.L., Batista I., Welch H.G., Wennberg D.E. (2002). Hospital volume and surgical mortality in the United States. New England Journal of Medicine, 346, 1128–1137
Brooks J.M., Irwin C.P., Hunsicker L.G., Flanigan M.J., Chrischilles E.A., Pendergast J.F. (2006). Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches. Health Services Research, 41(6): 2267–2289
Canadian Organ Replacement Register (2005). Treatment of end-stage organ failure in Canada 2002 and 2003. Ottawa: Canadian Institute for Health Information.
Cass A., Chadban S., Craig J., Howard K., McDonald S., Salkeld G., White S. (2006). The economic impact of end stage kidney disease in Australia. Sydney, The George Institute for International Health
Ceballos M., Lopez-Revuelta K., Caracho R., Garcia Lopez F., Castro P., Gutierrez J.A., Martin-Martinez E., Alonso R., Bernabeu R., Lorenzo V., Arias M., Sierra T., Estebanez C., Lara M., Cleries M., Vela E., Garcia-Blasco M.J., Zurriaga O., Vazquez C., Sanchez-Casajus A., Rodado R., Ripio J., Asin J.L., Magaz A. (2005). Informe de diálisis y trasplante correspondiente al año 2002 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrologia, 25(2), 121–124, 126–129.
Chalky M., Macomson J.H. (1998). Contracting for health services with unmonitored quality. The Economic Journal, 108(449): 1093–1110
Combe C., Pisoni R.L., Port F.K., Young E.W., Canaud B., Mapes D.L., Held P.J. (2001). Dialysis outcomes and practice patterns study: données sur l’utilisation des cathéters veineux centraux en hémodialyse chronique. Néphrologie, 22(8): 379–384
Conte F. (2004). Registro Italiano di Dialisi e Trapianto. Esperienza 1996–2001. Giornale Italiano di Nefrologia, 6, 561–567
Couchoud, C., Frimat, L., Aldigier, J. C., de Cornelissen, F., Dabot, C., Joyeuz, V., Labeeuw, M., Maheut, H., & Stengel, B. (2005). Incidence et évaluation des traitements de suppléance de l’insuffisance rénale chronique dans sept régions françaises en 2003. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 188–190.
Danovitch G.M., Cohen D.J., Weir M.R., Stock P.G., Bennett W.M., Christensen L.L., Sung R.S. (2005). Current status of kidney and pancreas transplantation in the United States, 1994–2003. American Journal of Transplantation, 5(4 Pt 2): 904–915
Danzon, P. M., & Furukawa, M. F. (2003). Prices and availability of pharmaceuticals: Evidence from nine countries. Health Affairs, Web exclusive (October 29, 2003)W3, 521–536.
Dawson D. (1994). Costs and prices in the internal market: Markets versus the executive management guideline. York, Centre for Health Economics. Working Paper n. 115.
De Negri A., Formica M., Cavagnino A. (1997). Valutazione dei costi dei trattamenti dialitici. Giornale Italiano di Nefrologia, 14, 325–329
De Vecchi A.F., Dratwa M., Wiedemann M.E. (1999). Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: Costs and reimbursement/funding of ESRD therapies. Nephrology Dialysis Transplantation, 14(Supp 6): 34–41
Deutschen Arbeitsgemeinschaft für Klinische Nephrologie (DAGKN) (2006). Dialysestandard 2006. Mitteilungen für Klinische Nephrologie, XXXV. Retrieved December 28, 2006, at http://www.nephrologie.de/ Dialysestandar2006.pdf
Dor A. (2004). Optimal price rules, administered prices and suboptimal prevention: Evidence from a Medicare program. Journal of Regulatory Economics, 25(1): 81–104
Durand-Zaleski, I., Combe, C., & Lang, P. (2007). International Study of Health Care Organization and Financing for end-stage renal disease in France. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9025-8
Frei, U., & Schober-Halstenberg, H-J. (2002). Annual report on dialysis treatment and renal transplantation in Germany for 2001/2002. Retrieved March 13, 2007, from http://www.quasi-niere.de/berichte/online/en/01/world.html
Fukuhara, S., Yamazaki, C., Hayashino, Y., Higashi, T., Eichleay, M. A., Akiba, T., Akizawa, T., Saito, A., Port, F. K., & Kurokawa, K. (2007). The organization and financing of end-stage renal disease treatment in Japan. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9017-8
Furniss A.L., Young E.W., Gillespie B.W., Akizawa T., Marshall M.R., Saito A., Wikström B., Keen M.L., Pisoni R.L. (2006). Catheter use predicts septicemia/endocarditis events for hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 17, 588A
Goodkin D.A., Bragg-Gresham J.L., Koenig K.G., Wolfe R.A., Akiba T., Andreucci V.E., Saito A., Rayner H.C., Kurokawa K., Port F.K., Held P.J., Young E.W. (2003). Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and The United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 14(12): 3270–3277
Green J., Passman L.J., Wintfeld N. (1991). Analyzing hospital mortality: The consequences of diversity in patient mix. Journal of the American Medical Association, 265, 1849–1853
Groupement des Nephrologues Francophones de Belgique (GNFB). (2002). Registre de Néphrologie de la Communauté Français de Belgique: Rapport annuel d’activité des Centres no 9—Année 2001. Brussels, Belgium.
Hakim R.M., Wingard R.L., Parker R.A. (1994). Effect of the dialysis membrane in the treatment of patients with acute renal failure. New England Journal of Medicine, 331(20): 1338–1342
Harris, A. (2007). The organization and funding of the treatment of end-stage renal disease in Australia. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9018-7
Hidai H. (2000). Need for an incentive-based reimbursement policy toward quality of care for dialysis care for dialysis patient management. Kidney International, 58, 363–373
Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9019-6
Hirth R.A., Tedeschi P.J., Wheeler J.R.C. (2001). Extent and sources of geographic variation in Medicare end-stage renal disease expenditures. American Journal of Kidney Diseases, 38(4): 824–831
Jacquelinet C., Savoye E., Kessler M., Durand D. (2005). Tendances et perspectives de la greffe rénale en France. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 191–192. Retrieved November 6, 2006, at http://www.invs.sante.fr/beh/2005/37_38/beh_37_38_2005.pdf
Jha V. (2004). End-stage renal disease in developing countries: The India experience. Renal Failure, 26(3): 201–208
Japanese Society for Dialysis Therapy (JSDT) (2002). An Overview of Regular Dialysis Treatment in Japan (as of December 31, 2000) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.
Japanese Society for Dialysis Therapy (JSDT) (2005). An overview of regular dialysis treatment in Japan (as of December 31, 2003) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.
Japanese Society for Dialysis Therapy (JSDT) (2006). A review of regular dialysis treatment in Japan (as of December 31, 2004)[in Japanese]. Tokyo: Japanese Society for Dialysis Therapy [CD Rom].
Kimura R. (1998). Organ transplantation and brain-death in Japan: Cultural, legal and bioethical background. Annals of Transplantation, 3(3): 55–58
Kleophas, W., & Reichel, H. (2007). International Study of Health Care Organization and Financing: Development of renal replacement therapy in Germany. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9020-0
Laupacis A., Keown P., Pus N., Krueger H., Ferguson B., Wong C.M Muirhead N. (1996). A study of the quality of life and cost-utility of renal transplantation. Kidney International, 50, 235-242
Lee H., Manns B., Taub K., Ghali W.A., Dean S., Johnson D., Donaldson C. (2002). Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases, 40(3): 611–622
Luño, J. (2007). The organization and financing of end-stage renal disease in Spain. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9021-z
Macron-Noguès, F., Vernay, M., Ekong, E., Lemaire, N., Salanave, B., Marty, M., Revel, M., Fender, P., & Allemand, H. (2005). La prévalence de l’insuffisance rénale chronique terminale traitée par dialyse en France en 2003: L’enquête nationale Sros-IRCT. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 182–184. Retrieved November 6, 2006, from http://www.invs.sante.fr/beh/2005/37_38/beh_37_38_2005.pdf
Mandelbrot, D. (1999). High-flux dialysis. In The kidney transplant/dialysis association patient handbook. Retrieved April 25, 2006, at http://msl1.mit.edu/ESD10/kidneys/HndbkHTML/contents.htm
Manns, B. J., Mendelssohn, D. C., & Taub, K. J. (2007). The economics of end-stage renal disease care in Canada: Incentives and impact on delivery of care. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9022-y
Mapes, D. L., Bodfish, L. J., Pisoni, R. L., Rayner, H. C., Young, E. W., & Held, P. J. (2001). Predictors of staffing practices in hemodialysis (HD) facilities: Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 12, 337A.
McNeill, D., & Coonan, C. (2006). Japanese flock to China for organ transplants. Japan Focus. Accessed December 8, 2006, at http://www.japanfocus.org/products/details/1818
Mendelssohn D.C., Kua B.T., Singer P.A. (1995). Referral for dialysis in Ontario. Archives of Internal Medicine, 1555, 2473–2478
Ministero della Salute, Centro Nazionale Trapianti. Attività donazione e trapianto 2004—dati al 31 dicembre 2004. Retrieved June, 2005, at http://www.ministerosalute.it/trapianti/normativa/statistiche.jsp
Nakai S., Shinzato T., Sanaka T., Kikuchi K., Kitaoka T., Shinoda T., Yamazaki C., Sakai R., Omori H., Morita O., Iseki K., Kubo K., Tabei K., Masakane I., Fushimi K., Wada A., Miwa N., Akiba T. (2002). The current state of chronic dialysis treatment in Japan (as of December 31, 2000). Journal of the Japan Society of Dialysis Therapy, 35(7): 1155–1184
National Kidney Foundation (2000). Clinical practice guidelines for nutrition in chronic renal failure. Retreived January, 2007, at http://www.kidney.org/professionals/KDOQI/guidelines_updates/doqi_nut.html
National Kidney Foundation (2006a). K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Retreived January, 2007, at http://www.kidney.org/professionals/KDOQI/guidelines_anemia/index.htm
National Kidney Foundation (2006b). Clinical practice guidelines and clinical practice recommendations: 2006 updates for hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access. Accessed January 2007 at http://www.kidney.org/professionals/KDOQI/guideline_upHD_PD_VA/va_guide8.htm
NBVN (2002). Annual Report 2002. Edegem, Belgium: Nederlandstalige Belgische Vereniging voor Nefrologie.
Nicholson, T., & Roderick, P. (2007). International Study of Health Care Organization and Financing of Renal Services in England and Wales. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9015-x
OECD. (2005). OECD in figures 2005 edition: Health spending and resources. Paris: Organization for Economic Cooperation and Development. Retrieved October, 2006, at http://www.oecd.org/topicstatsportal/ 0,2647, en_2825_495642_2757088_1_1_1_1,00.html
OECD (2006). Purchasing Power Parities (PPPs) for OECD countries 1980–2005. Paris: Organization for Economic Cooperation and Development. Retrieved October, 2006, at http://www.oecd.org/statisticsdata/0,2643,en_2649_34357_1_119656_1_1_1,00.html
Pauly M.V. (1993). U.S. health care costs: The untold true story. Health Affairs, 12(3): 152–159
Pauly M.V., Held P.J. (1990). Benign moral hazard. Journal of Health Economics, 9(4): 447–461
Pine M., Norusis M., Jones B., Rosenthal G.E. (1997). Predictions of hospital mortality rates: A comparison of data sources. Annals of Internal Medicine, 126(5): 347–354
Pisoni, R. L., Albert, J. M., Elder, S. E., Ethier, J., Kimata, N., Krishnan, M., Rayner, H. C., Saito, A., Sands, J., Saran, R., Wolfe, R. A., & Port, F. K. (2005). Lower mortality risk associated with native arteriovenous fistula (AVF) and graft (AVG) use in patient and facility-level analyses: Results from the DOPPS. Journal of the American Society of Nephrology, 16, 259A.
Pisoni R.L., Gillespie B.W., Dickinson D.M., Chen K., Kutner M., Wolfe R.A. (2004). The Dialysis Outcomes and Practice Patterns Study: Design, data elements, and methodology. American Journal of Kidney Diseases, 44 (Suppl 2): S7–S15
Pisoni, R. L., Young, E. W., Combe, C., Leavey, S. F., Greenwood, R. N., Hecking, E., Canaud, B. J., & F. (2001). Higher catheter use within facilities is associated with increased mortality and hospitalization: Results from DOPPS. Journal of the American Society of Nephrology, 12, 299A.
Pontoriero, G., Pozzoni, P., Del Vecchio, L., & Locatelli, F. (2007). International Study of Health Care Organization and Financing of renal replacement therapy in Italy: An evolving reality. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9016-9
Port F.K., Wolfe R.A., Hulbert-Shearon T.E., McCullough K.P., Ashby V.B., Held P.J. (2004). High dialysis dose is associated with lower mortality among women but not among men. American Journal of Kidney Diseases, 43(6): 1014–1023
Rayner H.C., Pisoni R.L., Bommer J., Canaud B., Hecking E., Locatelli F., Piera L., Bragg-Gresham J.L., Feldman H.I., Goodkin D.A., Gillespie B., Wolfe R.A., Held P.J., Port F.K. (2004). Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation, 19(1): 108–120
Saran R., Bragg-Gresham J.L., Levin N.W., Twardowski Z.J., Wizemann V., Saito A., Kimata N., Gillespie B.W., Combe C., Bommer J., Akiba T., Mapes D.L., Young E.W., Port F.K. (2006). Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney International, 69(7): 1222–1228
Svenskt Register för Aktiv Uremivård (SRAU) (2003). Aktiv uremivård i sverige: 1991–2002. Retrieved February 19, 2007, from http://www.socialstyrelsen.se/NR/rdonlyres/AC1A8C40-F4B8-4297-A24B-E7671B8CC31E/0/kva023r03.pdf.
Szczech L.A., Klassen P.S., Chua B., Hedayati S.S., Flanigan M., McClellan W.M., Reddan D.N., Rettig R.A., Frankenfield D.L., Owen W.F. Jr. (2006). Assocations between CMS’s clinical performance measures project benchmarks, profit structure, and mortality in dialysis units. Kidney International, 69(11): 2094–2100
TRANSPLANeT (2007). The number of presently registered people. Community Data File, Japan Organ Transplant Network. Retrieved December 8, 2006, at http://translate.google.com/translate?hl=en&sl=ja&u= http://www.jotnw.or.jp/&sa=X&oi=translate&resnum=2&ct=result&prev=/search%3Fq%3Djapan%2 Borgan%2Btransplant%2Bnetwork%26hl%3Den%26lr%3D%26sa%3DG
Twardowski Z.J. (2006). Dialyzer reuse—part II: Advantages and disadvantages. Seminars Dialysis, 19(3): 217–226
U.S. Census Bureau (2006). International data base. Washington, DC: U.S. Census Bureau. Retrieved 18, 2006, at http://www.census.gov/ipc/www/idbnew.html
USRDS (2005). Annual data report: Atlas of end stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases.
Van Biesen, W., Lameire, N., Peeters, P., & Vanholder, R. (2007). Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9013-z
Wennberg, J. E., Fisher, E. S, & Skinner, J. S. (2002). Geography and the debate over Medicare reform. Health Affairs, Supp Web Exclusives, W96–114.
Wikström, B., Fored, M., Eichleay, M. A., & Jacobson, S. H. (2007). The financing and organization of medical care for patients with end-stage renal disease in Sweden. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9013-y
Wolfe R.A., Ashby V.B., Milford E.L., Akinlolu O.O., Ettenger R.E., Agodoa L.Y.C., Held P.J., Port F.K. (1999). Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine, 341, 1725–1730
Wordsworth S., Ludbrook A. (2005). Comparing costing results in across country economic evaluations: The use of technology specific purchasing power parities. Health Economics, 14, 93–99
World Bank (2004). GNI per capita 2002: Atlas method and PPP. World Development Indicators database. Retrieved April 6, 2007, at http://www.adoptadoctor.org/gni.pdf
World Health Organization (2006). WHO Statistical Information System: Life tables for WHO member states. Retrieved December, 2006, at http://www3.who.int/whosis/life/life_tables/life_tables.cfm? path=life,life_tables&language=english
Yoshino M., Kuhlmann M.K., Greenwood R.N., Pisoni R.L., Port F.K., Jager K.J., Homel P., Augustijn H., de Charro F.T., Collart F., Erek E., Finne P., Garcia-Garcia G., Grönhagen-Riska C., Ioannidis G.A., Ivis F., Leivestad T., Løkkegaard H., Lopot F., Jin D.C., Kotanko P., Kramar R., Nakao T., Nandakumar M., Ramirez S., van der Sande F.M., Schön S., Simpson K., Walker R.G., Zaluska W., Levin N.W. (2006). International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. Journal of the American Society of Nephrology, 17, 3510–3519
Young E.W., Dykstra D.M., Goodkin D.A., Mapes D.L., Wolfe R.A., Held P.J. (2002). Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). International Society of Nephrology, 61, 2266–2271
Young E.W., Goodkin D.A., Mapes D.L., Port F.K., Keen M.L., Chen K., Maroni B.L., Wolfe R.A., Held P.J. (2000). The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney International, 57(Suppl 74): S74–S81
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dor, A., Pauly, M.V., Eichleay, M.A. et al. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 7, 73–111 (2007). https://doi.org/10.1007/s10754-007-9024-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10754-007-9024-9
Keywords
- End-stage renal disease
- Dialysis
- Health care financing
- Incentives
- Medical costs
- Reimbursement
- Transplantation